BLOG

Fierce-Biotech

Merck is back in Alzheimer’s saddle with $1B+ Cerevance pact, years after dropping the BACE

Cerevance is a central nervous system disorders-focused biotech backed by Bill Gates. Its main program so far has been the Parkinson’s disease therapy CVN424, which